Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haanen

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Sulindac and its derivatives: a novel class of anticancer agentsC Haanen
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2000
[Apoptosis as a focal point for prognostic and therapeutic interventions in clinical medicine]C Haanen, I Vermes
Mediators of Inflammation|January 1, 1995
Apoptosis and inflammationC Haanen, I Vermes
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1996
Apoptosis: programmed cell death in fetal developmentC Haanen, I Vermes
Scandinavian Journal of Haematology|April 1, 1986
A possible role of rifampicin in prolonging remission duration in acute myelogenous leukaemiaJ Burghouts, C Haanen
Nederlands Tijdschrift Voor Geneeskunde|September 24, 1999
[Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine]C Haanen, I Vermes
Tropical and Geographical Medicine|June 1, 1979
Blastomycosis treated successfully with miconazoleP A Bleeker, C Haanen
Lancet (London, England)|October 18, 1975
"Incubation period" in Hodgkin's diseaseD J Wagener, C Haanen
Nederlands Tijdschrift Voor Geneeskunde|April 8, 1995
[Chronic arthralgia: not a precursor of rheumatoid arthritis, but part of fibromyalgia syndrome]A Salet, H C Haanen
European Journal of Clinical Investigation|August 1, 1977
Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's diseaseD J Wagener, C Haanen
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Sulindac and its derivatives: a novel class of anticancer agentsC Haanen
Nederlands Tijdschrift Voor Geneeskunde|August 3, 2000
[Apoptosis as a focal point for prognostic and therapeutic interventions in clinical medicine]C Haanen, I Vermes
Mediators of Inflammation|January 1, 1995
Apoptosis and inflammationC Haanen, I Vermes
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1996
Apoptosis: programmed cell death in fetal developmentC Haanen, I Vermes
Scandinavian Journal of Haematology|April 1, 1986
A possible role of rifampicin in prolonging remission duration in acute myelogenous leukaemiaJ Burghouts, C Haanen
Nederlands Tijdschrift Voor Geneeskunde|September 24, 1999
[Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine]C Haanen, I Vermes
Tropical and Geographical Medicine|June 1, 1979
Blastomycosis treated successfully with miconazoleP A Bleeker, C Haanen
Lancet (London, England)|October 18, 1975
"Incubation period" in Hodgkin's diseaseD J Wagener, C Haanen
Nederlands Tijdschrift Voor Geneeskunde|April 8, 1995
[Chronic arthralgia: not a precursor of rheumatoid arthritis, but part of fibromyalgia syndrome]A Salet, H C Haanen
European Journal of Clinical Investigation|August 1, 1977
Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's diseaseD J Wagener, C Haanen
Pageof 17